Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00954564 · ClinicalTrials.gov registry record
Joint Pain and Medication Adherence in Postmenopausal Women Receiving Aromatase Inhibitors
A clinical trial of Breast Cancer and Arthralgia, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 351
- Enrollment target
- 2
- Study locations
NCT00954564: Completed study of Breast Cancer and Arthralgia, sponsored by Vanderbilt University Medical Center.
NCT00954564 is a study of Breast Cancer and Arthralgia that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 351 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00954564, a study of Breast Cancer and Arthralgia, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 351 participants
- Enrollment target
- 2
- Study locations
Study Summary
RATIONALE: Gathering information over time about joint pain and stiffness from postmenopausal women with early-stage breast cancer who are receiving aromatase inhibitors may help doctors plan treatment and help patients live more comfortably. PURPOSE: This observational epidemiologic cohort is designed to study arthralgia, patient-reported outcomes, and medication adherence in postmenopausal women with early-stage breast cancer who are receiving aromatase inhibitors.
Conditions Studied
Interventions
- OTHER medical chart review
- OTHER questionnaire administration
- PROCEDURE assessment of therapy complications
- OTHER aromatase inhibition therapy - OBSERVATIONAL ONLY
Study Locations (2)
Tennessee
- Vanderbilt-Ingram Cancer Center - Nashville
- Vanderbilt-Ingram Cancer Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 351 participants |
| Start Date | 2009-06 |
| Est. Completion | 2014-05 |
What the finished NCT00954564 record still lists
NCT00954564 is an observational study that tracks outcomes without assigning an intervention. The registered 351 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 4 interventions - of which medical chart review is the first listed.
NCT00954564 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00954564 about?
NCT00954564 is a clinical study titled "Joint Pain and Medication Adherence in Postmenopausal Women Receiving Aromatase Inhibitors". RATIONALE: Gathering information over time about joint pain and stiffness from postmenopausal women with early-stage breast cancer who are receiving aromatase inhibitors may help doctors plan treatment and help patients live more comfortably. PURPOSE: This observational epidemiologic cohort is desi...
What is the current status of trial NCT00954564?
This trial is currently completed. The enrollment target is 351 participants. The study started on 2009-06. Estimated completion is 2014-05.
What conditions does trial NCT00954564 study?
This clinical trial studies the following conditions: Breast Cancer, Arthralgia.
What interventions are being tested in trial NCT00954564?
The interventions under investigation include: medical chart review (OTHER), questionnaire administration (OTHER), assessment of therapy complications (PROCEDURE), aromatase inhibition therapy - OBSERVATIONAL ONLY (OTHER).
Who is sponsoring clinical trial NCT00954564?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00954564 being conducted?
This trial has 2 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00954564's enrollment target sits among peer trials
351 257th of 1224 higher than 968 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06241456 · 351 participants · Phase 1
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
- NCT06576726 · 351 participants
Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder
- NCT07043400 · 351 participants · Phase 3
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT07261423 · 351 participants · NA
Pollution Intervention to Impact Kids Asthma Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia